← Open Payments lookup

ARJUMAND JAFFRI: Open Payments

NPI 1205976602 · SMITHVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$439 in 26 payments from 9 companies in 2025. Trend: 2023 $343 · 2024 $547 · 2025 $439

Food & beverage: $431Education: $8
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.11$138
ABBVIE INC.3$65
Vanda Pharmaceuticals Inc.2$56
E.R. Squibb & Sons, L.L.C.3$49
Alkermes, Inc.2$35
Lundbeck LLC1$33
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$32
Janssen Pharmaceuticals, Inc1$16
Teva Pharmaceuticals USA, Inc.1$14

Products named: REXULTI, VRAYLAR, FANAPT, COBENFY, ABILIFY MAINTENA, ARISTADA, ABILIFY ASIMTUFII, CAPLYTA.

Industry payments across MO — which companies pay providers there.